Andrew Merken is a Shareholder (Partner) at Polsinelli, an AM LAW 100 firm with over 1200 lawyers in 25 offices, where he serves as a member of Polsinelli’s Life Sciences Leadership Team. Andy focuses on corporate and transactional matters for a wide variety of clients covering the entire business life cycle, from start-up (formation and organization) to seed and venture stage funding to growth stage (later stage funding, corporate collaborations and buy-side M&A) and ultimately exit (sell-side M&A or IPO).  Andy actively works with his clients in all such phases and often serves as outside general counsel to his clients.
On the institutional side, Andy represents VC funds, angel investors, family offices and private foundations in investing in and/or collaborating with their portfolio companies and also has represented investment banks in public offerings, private placements and M&A transactions.
Andy works primarily with life sciences/health care companies (biotech, pharma, medical device, digital health and health care) and tech companies but also represents clients in such industries as consulting, real estate, professional services and consumer goods.
Andy has a long history of community and industry involvement; he currently serves on the ACS CAN Breakfast Event Committee, the Board of Advisors of the Lappin Foundation, the Board of Advisors of the Derby Entrepreneurship Center at Tufts, the Council (Board of Directors) of the Boston Bar Association, the Tufts Alumni Council (Emeritus Member) and the Board of Directors of the Alliance of Merger & Acquisition Advisors New England Chapter. Andy received a B.A. in Economics from Tufts University and a J.D. from the University of Pennsylvania Law School, where he served as Managing Editor of the Comparative Labor Law Journal.

BACK